IMMX
Immix Biopharma·NASDAQ
--
--(--)
--
--(--)
IMMX fundamentals
Immix Biopharma (IMMX) released its earnings on Aug 8, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.22 (YoY -46.67%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.22
-46.67%
Report date
Aug 8, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Immix Biopharma (IMMX) key financial stats and ratios, covering profitability, financial health, and leverage.
Immix Biopharma (IMMX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immix Biopharma (IMMX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immix Biopharma (IMMX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immix Biopharma (IMMX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immix Biopharma (IMMX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Immix Biopharma's management provide for the next earnings period?Did Immix Biopharma beat or miss consensus estimates last quarter?What is Immix Biopharma's gross profit margin?What were the key takeaways from Immix Biopharma’s earnings call?What is the market's earnings forecast for Immix Biopharma next quarter?What is Immix Biopharma's latest dividend and current dividend yield?What factors drove the changes in Immix Biopharma's revenue and profit?What were the key takeaways from Immix Biopharma's earnings call?
